Walleye Capital’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-200,000
Closed -$1.66M 4499
2022
Q4
$1.66M Sell
200,000
-888
-0.4% -$17.4K 0.03% 683
2022
Q3
$6.47M Buy
200,888
+113,122
+129% +$4.19M 0.12% 177
2022
Q2
$3.53M Buy
87,766
+72,268
+466% +$5.28M 0.1% 232
2022
Q1
$1.66M Buy
15,498
+14,842
+2,263% +$2.33M 0.04% 425
2021
Q4
$164K Buy
+656
New +$146K 0.01% 1536
2021
Q3
Sell
-549
Closed -$110 1876
2021
Q2
$110 Hold
549
﹤0.01% 1161
2021
Q1
$111 Sell
549
-1,407
-72% -$306K 0.01% 1023
2020
Q4
$417 Buy
+1,956
New +$407K 0.03% 533

Other funds holding SNCE

Walleye Capital's SNCE Position: Q1 2023 in Review

Walleye Capital sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2023, closing a stake of 200,000 shares — an estimated $1.66M sold.

Walleye Capital first reported a position in SNCE in Q4 2020 and held it in 8 quarters. The position peaked at $6.47M in Q3 2022. 56 funds tracked by Wall St. Rank hold SNCE as of Q1 2023.

  • Walleye Capital reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 200,000 Science 37 Holdings, Inc. Common Stock shares in Q1 2023, an estimated $1.66M.
  • Walleye Capital first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Walleye Capital's Science 37 Holdings, Inc. Common Stock position peaked at $6.47M in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.